Melatonin

8

Review clinical trials related to Melatonin. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Effects of Melatonin on Sleep Architecture of Critically Ill Patients in the ICU

This is a pilot study to examine the effects of melatonin on the sleep patterns of critically ill patients. Patients will have their sleep patterns measured with a device attached to their head with a headband then be given a dose of melatonin. Their participation in the study will last two days.

Participants needed: 30
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Rutgers, The State University of New JerseyUpdated: Jul 13, 2026
Eligibility criteria

18 years or older, admitted to the ICU [+5]

Mechanically ventilated [+4]

Status: Not yet recruiting

Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin

This study aims to assess the cardioprotective effect of melatonin and vitamin D in breast cancer patients who receive doxorubicin.

Participants needed: 90
Trial details
Age: 18-65Biological sex: FemaleType: InterventionalSponsor: Tanta UniversityUpdated: Jan 16, 2026Locations: 1
Eligibility criteria

Age from 18 to 65 years old. [+5]

Pregnant or breastfeeding women. [+6]

Status: Recruiting

Light in Frail Elderly - the Effect of a Dynamic Light for Sleep and Circadian Rhythm

The aim of this project is to evaluate the effect of a dynamic light in order to improve the circadian rhythm, provide a better sleep and well-being, and in the long run an improved recovery. The primary question is whether dynamic artificial light with circadian stimulus can affect the circadian rhythm. The secondary question is whether this also provides better sleep and well-being. The group that is particularly interesting to study is a geriatric population that is more sensitive to circadian rhythm disorders, sleep disorders and confusion in connection with hospitalization and that can be of particular benefit from this intervention.

Participants needed: 300
Trial details
Age: 65+Biological sex: AllType: InterventionalSponsor: Region SkaneUpdated: Jan 12, 2026Locations: 1
Eligibility criteria

Over the age of 65 years [+1]

Overdose addictive substance [+10]

Status: Recruiting

Light in Healthcare Environment (Ljus i sjukhusmiljö)

The goal of this clinical trial is to learn if light can enhance the feeling of well-being and sleep quality in Radiographers. It will also find out if there is an optimal recipe for light. The main questions it aims to answer are: * Will alertness, energy levels, and sleep quality increase in radiographers when the lighting is differed? * What light recipe is the most beneficial for the personnel? Researchers will compare no enhanced light environment to different enhanced light environment to see if the enhanced light is beneficial for radiographers. Participants will: * Will work in an enhanced light environment or a non-enhanced light environment * Answer surveys * Take saliva sample

Participants needed: 18
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Lund UniversityUpdated: Dec 2, 2025Locations: 3
Eligibility criteria

Not listed

Status: Not yet recruiting

Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy

The goal of this clinical trial is to learn if oral melatonin can enhance visual acuity and central macular thickness in central serous chorioretinopathy (CSCR) in adults. The main questions it aims to answer are: 1. How does melatonin affect central macula thickness in CSCR? 2. How does melatonin affect visual acuity in CSCR? Researchers will compare placebo (a look-like substance that contains no drug) to see if melatonin works to treat CSCR. Participants will: 1. Take melatonin or placebo twice a day for one month 2. Visit the clinic after finishing a course of treatment, and 1 and 3 months after that for visual acuity assessment and tests 3. Keep a diary of their symptoms

Participants needed: 48
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Mohsen PouraziziUpdated: Feb 5, 2025
Eligibility criteria

Patients whose diagnosis of central serous chorioretinopathy is confirmed based... [+2]

A history of vitrectomy [+7]

Status: Not yet recruiting

Effects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease Spectrum

The goal of this clinical trial is to explore and verify the preventive effects of melatonin on the progression of Alzheimer's disease. The study aims to analyze the changes in blood biomarkers (phosphorylated tau, glial fibrillary acidic protein, neurofilament chain), various sleep-related subjective report questionnaire scores, physical performance, cognitive function scores and cerebellar volume change after three months of melatonin administration in patients with Alzheimer's-type mild cognitive impairment (MCI) accompanied by insomnia. The main questions it aims to answer are: 1. Does melatonin administration alter the levels of blood biomarkers associated with Alzheimer's disease? 2. What changes occur in sleep-related subjective report questionnaire scores and cognitive function scores following melatonin administration? 3. Does melatonin administration effect on physical performance? 4. Is there any relations between cognitive decline, phsycal performance and cerebellar volume change? We will compare the data collected before and after melatonin administration to determine its preventive effects on Alzheimer's disease progression. Participants Will: 1. Take melatonin every day for 3 months and Complete sleep-related subjective report questionnaires, neuropsychological assessments and physical performance test 2. Visit the clinic at the initial visit and after 3 months for checkups and tests. 3. Complete sleep-related subjective report questionnaires and neuropsychological assessments and physical performance test 4. Provide blood samples for biomarker analysis.

Participants needed: 40
Trial details
Age: 60-90Biological sex: AllType: InterventionalSponsor: Saint Vincent's Hospital, KoreaUpdated: Jan 3, 2025
Eligibility criteria

Male and female participants aged 60 to 90 years [+7]

Individuals with progressive mental or neurological disorders (including those w... [+5]

Status: Recruiting

Idiopathic Scoliosis New Onset and Melatonin Phase Delay in Children

This study aimed to investigate the prevalence and clinical significance of melatonin phase delay in children with new onset and progressive idiopathic scoliosis (IS).

Participants needed: 956
Trial details
Age: 6-15Biological sex: AllType: ObservationalSponsor: Second Affiliated Hospital of Wenzhou Medical UniversityUpdated: Jul 16, 2024Locations: 1
Eligibility criteria

Collect saliva according to standards and complete melatonin testing [+5]